서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 121 to 171 of 171

Issue DateTitle / Author(s) / CitationFileAltmetrics
2020-10
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
DOI
2020-11
The Importance of Proper History Taking: Asking a Fever Pattern in Patients with Vivax Malaria

Chang, Euijin; Song, Kyoung-Ho; Park, Wan Beom; Bang, Ji Hwan; Kim, Eu Suk; Park, Sang Won; Kim, Nam Joong

Journal of Korean Medical Science, Vol.35 No.43, p. e386

DOI
2020-12
Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors
DOI
2021-01
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
DOI
2021-01
Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
DOI
2021-01
Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
view fileDOI
2021-03
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection
DOI
2021-04
Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection
DOI
2021-05
Impact of a computerised clinical decision support system on vancomycin loading and the risk of nephrotoxicity
DOI
2021-05
Antibody Responses One Year after Mild SARS-CoV-2 Infection
DOI
2021-07
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2021-08
Effect of Perioperative Subglottic Secretion Drainage on Ventilator-Associated Pneumonia After Cardiac Surgery: A Retrospective, Before-and-After Study
DOI
2021-09
Persistence of Neutralizing Antibody Response up to 1 Year after Asymptomatic or Symptomatic SARS-CoV-2 Infection
DOI
2021-10
Clonal hematopoiesis is associated with risk of severe Covid-19
DOI
2021-10
Work Restrictions for Healthcare Personnel with Potential In-hospital Exposure to SARS-CoV-2: Experience at a Tertiary Hospital
DOI
2021-11
Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
DOI
2021-12
Surface-Aerosol Stability and Pathogenicity of Diverse Middle East Respiratory Syndrome Coronavirus Strains, 2012-2018
DOI
2021-12
A Direct Rapid Phenotypic Antimicrobial Susceptibility Test Enables Early Selection of Optimal Antibiotics to Treat Bacteremia in COVID-19 Patients
DOI
2021-12
Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients

Lee, Chan Mi; Lee, Eunyoung; Bang, Ji Hwan; Park, Sang-Won; Park, Wan Beom; Oh, Myoung-Don; Kim, Nam Joong

Infection and Chemotherapy, Vol.53 No.4, pp.792-795

DOI
2022-01
SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
DOI
2022-01
Clinical Impact of Empirical Antibiotic Therapy in Patients With Coronavirus Disease 2019 Requiring Oxygen Therapy
DOI
2022-02
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic
DOI
2022-03
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
DOI
2022-03
Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS-441524 in patients with COVID-19: A limited case series
DOI
2022-04
Changes in Anxiety Level and Personal Protective Equipment Use Among Healthcare Workers Exposed to COVID-19
DOI
2022-05
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
DOI
2022-05
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity (vol 13, 830433, 2022)
DOI
2022-07
Effectiveness of antimicrobial stewardship programmes based on rapid antibiotic susceptibility testing of haematological patients having high-risk factors for bacteraemia-related mortality: a post-hoc analysis of a randomised controlled trial

Kim, Jeong-Han; Kim, Taek Soo; Chang, Euijin; Kang, Chang Kyung; Choe, Pyoeng Gyun; Kim, Nam Joong; Oh, Myoung-don; Park, Wan Beom; Kim, Inho

International Journal of Antimicrobial Agents, Vol.60 No.1, p. 106604

DOI
2022-07
Different levels of humoral and cellular immunity to varicella-zoster virus in seropositive healthcare workers
DOI
2022-08
Positivity rates of mycobacterial culture in patients with tuberculous spondylitis according to methods and sites of biopsies: An analysis of 206 cases
DOI
2022-09
Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2022-11
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
DOI
2022-11
Accurate Diagnosis of COVID-19 from Self-Collectable Biospecimens Using Synthetic Apolipoprotein H Peptide-Coated Nanoparticle Assay
DOI
2022-12
Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment
DOI
2022-12
Clinical and economic burden of bacteremia due to multidrug-resistant organisms in Korea: a prospective case control study
DOI
2022-12
Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
DOI
2022-12
Clinical Characteristics of Patients with Probable Coronavirus Disease 2019-associated Pulmonary Aspergillosis at a Tertiary Care Hospital in the Republic of Korea: A Case Series
DOI
2022-12
How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea

Park, Do Hyeon; Kang, Chang Kyung; Choe, Pyoeng Gyun; Kim, Nam Joong; Park, Wan Beom; Oh, Myoung Don

Journal of Korean Medical Science, Vol.37 No.49, p. e353

DOI
2022-12
Clinical application of the Panbio™ COVID-19 Ag rapid test device and SSf-COVID19 kit for the detection of SARS-CoV-2 infection
view filelink
2023-01
Clinical impact of clonal hematopoiesis on severe COVID-19 patients without canonical risk factors
DOI
2023-02
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals
DOI
2023-03
Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
DOI
2023-04
Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19
DOI
2023-04
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection (vol 224, jiab159, 2021)
DOI
2023-06
Effect of Wearing Personal Protective Equipment (PPE) for COVID-19 Treatment on Blood Culture Contamination: Implication for Optimal PPE Strategies
DOI
2023-10
Impact of routine brain imaging on the prognosis of patients with left-sided valve infective endocarditis without neurological manifestations
DOI
2023-10
Empirical vs pre-emptive broad-spectrum antifungal therapy for acute myelogenous leukaemia in the era of antimould prophylaxis
DOI
2023-11
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories
DOI
2023-12
Possibility of Decreasing Incidence of Human Immunodeficiency Virus Infection in Korea
DOI
2024-01
Impact of T-Cell Engagers on COVID-19-Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy
DOI
2024-02
Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era
DOI
1 2 3